文献速递主动脉外科

使用混合型支架的冷冻象鼻技术:单中心15年结局

Frozen elephant trunk technique using hybrid grafts: 15-year outcomes from a single-centre experience.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

本研究比较2007年1月至2022年7月单中心367例接受冷冻象鼻技术(FET)患者使用两种混合型支架的短期和长期结局。Thoraflex组较E-Vita组远端吻合更多位于2区、支架段更短、内脏缺血时间更短。2013—2022年期间两组总体生存无显著差异,但Thoraflex组免于TEVAR率显著较低,竞争风险分析显示Thoraflex组随访期间接受TEVAR的可能性更高(SHR=2.12,95%CI 1.06-4.22)。

要点

  • 367例FET手术中,E-Vita Open占49.3%,Thoraflex Hybrid占50.7%,年均手术量22.7例/年。
  • Thoraflex组远端吻合2区比例68.3% vs E-Vita组11.6%(P<0.001),支架段更短,内脏缺血时间更短。
  • 2013—2022年两组总体生存无显著差异(P=0.907),但Thoraflex组免于TEVAR率显著较低(P=0.029)。

核心结论

  • FET技术可处理急性和慢性主动脉弓疾病,并发症发生率和死亡率可接受。
  • 随访期间远端血管内再干预非常常见。

研究设计与样本

  • 单中心研究,纳入2007年1月至2022年7月接受择期或急诊FET手术的患者,共367例。
  • 比较E-Vita Open与Thoraflex Hybrid两种混合型支架的短期和长期结局。
  • 主要终点为短期死亡率、长期死亡率和免于胸主动脉腔内修复(TEVAR)。
  • 分析分别按2007—2012年和2013—2022年两个时间段进行。

主要发现

  • 总体平均年龄61岁(标准差=11),男性占80.7%,FET手术年均手术量22.7例/年。
  • Thoraflex组远端吻合位于2区比例68.3% vs E-Vita组11.6%(P<0.001)。
  • Thoraflex组支架段平均长度103 mm(标准差=11.3)vs E-Vita组平均149 mm(标准差=12.7),P<0.001。
  • Thoraflex组内脏缺血时间平均42.5 min(标准差=14.2)vs E-Vita组平均61.0 min(标准差=20.2),P<0.001。
  • 2013—2022年期间,Thoraflex组1、2、5年总体生存率分别为74.8%、72.5%、63.2%,E-Vita组分别为73.2%、70.7%、64.1%,两组无显著差异(log-rank检验=0.01,P=0.907)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The purpose of the study is to compare the short- and long-term outcomes of the frozen elephant trunk (FET) technique based on 2 different hybrid grafts implanted from January 2007 to July 2022. METHODS: The study includes patients who underwent an elective or emergency FET procedure. Short-term, long-term mortality and freedom from thoracic endovascular aortic repair (TEVAR) were the primary end points. Analyses were carried out separately for the periods 2007-2012 and 2013-2022. RESULTS: Of the 367 enrolled, 49.3% received E-Vita Open implantation and 50.7% received Thoraflex Hybrid implants. Overall mean age was 61 years [standard deviation (SD) = 11] and 80.7% were male. The average annual volume of FET procedures was 22.7 cases/year. Compared to E-Vita Open, patients implanted with Thoraflex Hybrid grafts were more likely to receive distal anastomosis in zone 2 (68.3% vs 11.6%, P < 0.001) with a shorter stent portion, mean = 103mm (SD = 11.3) vs mean = 149 mm (SD = 12.7; P < 0.001) and they underwent a reduced visceral ischaemia time, mean = 42.5 (SD = 14.2) vs mean= 61.0 (SD = 20.2) min, P < 0.001. In the period 2013-2022, overall survival at 1, 2 and 5 years was 74.8%, 72.5% and 63.2% for Thoraflex and 73.2%, 70.7% and 64.1% for E-Vita, without significant differences between groups (log-rank test = 0.01, P = 0.907). Overall freedom from TEVAR at 1, 2 and 5 years was 66.7%, 57.6% and 39.3% for Thoraflex and 79%, 69.7% and 66% for E-Vita, with significant differences between groups (log-rank test = 5.28, P = 0.029). In a competing risk analysis adjusted for chronic/residual aortic syndromes and stent diameter, the Thoraflex group was more likely to receive TEVAR during follow-up (subdistribution hazard ratio SHR = 2.12, 95% confidence interval 1.06-4.22). CONCLUSIONS: The FET technique addresses acute and chronic arch disease with acceptable morbidity and mortality. Downstream endovascular reinterventions are very common during follow-up.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Murana G, Gliozzi G, Di Marco L, et al. Frozen elephant trunk technique using hybrid grafts: 15-year outcomes from a single-centre experience. Eur J Cardiothorac Surg. 2024. PMID: 37930039. doi:10.1093/ejcts/ezad364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。